| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  MedBrain Reliable diagnostic support for healthcare professionals working in low and middle-income nations. 🩺 MedBrain is a diagnostic support system for healthcare professionals in low and middle-income nations. MedBrain can deliver a reliable clinical diagnosis (Accuracy: >83%) whenever diagnostic tests are not available. 🔴 Problem: 'Half of the world’s population has no access to basic diagnostic resources' - The Lancet. The diagnostic hardware paradigm is perpetuating the global diagnostic gap. 🔵 Solution: By leveraging data science and clinical evidence, MedBrain delivers a reliable clinical diagnosis to every patient, entirely for free. ✅ Validation: We have demonstrated a market-leading 83% Diagnostic Accuracy … Type: | 1 | 1 | 0 | 6 |
 |  Oculis Oculis (Nasdaq: OCS) is a global biopharmaceutical company purposefully driven to save sight and improve eye care. Oculis’ highly differentiated clinical-stage pipeline comprises multiple innovative product candidates in development for eye diseases of high unmet need. It includes OCS-01 eye drops, a topical candidate in Phase 3 development for diabetic macular edema (DME) and inflammation and pain following ocular surgery; OCS-02 eye drops, a topical biologic candidate in Phase 2 development for dry eye disease (DED) and uveitis; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophthalmic disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, … Type: | 3 | 1 | 2 | 39 |
 | Heima Creative living in nature We develop eco-resorts in pristine natural environments that spark and harness discovery in all of its facets: from outdoors adventures to inner journeys. Our global homes are living ecosystems blurring the boundaries between resort and surroundings. A unique opportunity to unlock a lifestyle closer to nature and one’s own truth. Tourism, Cabins, Hospitality, Developments, and Retreats Type: | 0 | 0 | 0 | 5 |
 | Circio Holding ASA Developing novel circular RNA and immunotherapy medicines. Circio Holding ASA is a clinical stage company developing immune activators to target difficult-to-treat diseases. The company’s mission is to deploy vector-based technology to create a novel class of targeted, multi-functional circRNA medicines. It has established a cutting-edge circular RNA (circRNA) program and is collaborating with Prof Michael Uhlin and a team at the Karolinska Institutet in Stockholm with the intent to develop next generation RNA therapeutics for various applications. The company also has a mutant RAS cancer vaccine program, with two collaborative clinical trials underway in the USA and Norway. It is … Type: | 0 | 0 | 0 | 21 |
 | PainNavigator Digital therapy platform for pain management providers - remote care & billing for patients with chronic pain. PainNavigator is a digital therapy platform that supports tracking patient outcomes & unlocks remote care & billing for pain management providers. PainNavigator provides an accessible and evidence-based interdisciplinary therapeutic program for patients with acute and chronic nonsurgical pain. Type: | 0 | 0 | 0 | 9 |
 | Lys Therapeutics First-in-class biotherapies against neurological diseases. Targeting neuroinflammation to tackle neurodegeneration. Lys Therapeutics is a biotechnology company pioneering a breakthrough approach to treat patients suffering from neurodegenerative or neurovascular disorders. Its main drug is a first-in-class monoclonal antibody, Glunozumab, displaying an exclusive and groundbreaking mechanism of action. It is demonstrated that one endogenous protease called tissue plasminogen activator (tPA) is implicated in the pathophysiology of neurological diseases such as multiple sclerosis, Parkinson’s disease, stroke and other neurodegenerative disorders through its overexpression and binding to NMDA receptors (NMDAr) present on vascular endothelial cells and regulating the blood brain barrier (BBB) function / … Type: | 13 | 4 | 8 | 12 |
 | Mello Enabling probiotics and bioactives for healthier, more sustainable solutions of tomorrow Mello aims to enable the powerful effect of probiotics and bioactives so that they can be used to enhance your health and wellbeing. We're pioneering a groundbreaking encapsulation ?technology securing unparalleled effectiveness in the human body. Our unique delivery solutions will solve the longstanding challenge of delivering bioactives, to a specific target location in the body, effectively. Probiotic encapsulation, micro-encapsulation, and Encapsulation technology Type: | 1 | 1 | 0 | 10 |
 | CS MEDICA Denmark-based group of companies focused on production and distribution of OTC CBD medical devices and cosmetics. CS MEDICA is a group of two fully-owned, Denmark-based subsidiaries: Galaxa Pharma A/S and CanNordic A/S, whereby CanNordic A/S is a registered Medical Device product developer and Galaxa Pharma A/S is product distributor in the Nordic Region. We see ourselves as a company in constant development, exploring the ways in which we can support patients in their battle against the disease, the pain and the sorrow it brings. Medical Device, Pharmaceuticals, Cosmetics, Regulatory Affairs, Distribution, Manufacturing, Cannabinoids, and CBD Type: | 0 | 0 | 0 | 6 |
 | OQmented Disruption and Augmentation enabled by a miniature laser scanning device OQmented is a company with offices in Germany and the United States that is developing fully integrated, ultra-compact MEMS-based laser beam scanning projection display systems for Augmented Reality devices and automotive applications as well as best-in-class 3D sensing solutions for mobile and stationary applications. Our light engines combine sophisticated MEMS mirrors with proprietary electronics and software. We achieve the highest performance in terms of field of view, device size, durability, energy consumption, sensing, and resolution. Among our customers are technology, automotive and optics companies who choose OQmented to power their … | 6 | 0 | 6 | 70 |
 | Presentient Technologies Ltd Predicting the future: faster clinical trials Since the 1950s, the cost to develop a drug has been doubling every 9 years meaning fewer affordable drugs - Presentient wants to help stop trials the moment enough evidence has been collected, accelerating all clinical research and saving pharma tens of billions. Clinical trials and Data analytics Type: | 0 | 0 | 0 | 3 |
 | Lgem | synalgae Reliable systems for producing any algae at any scale Lgem|Synalgae is biotech scale up merger between Lgem with more than 15 years experience in building PBR systems and growing algae and Synalgae a High-Tec conglomerate specialised in process technology. Together we provide a high-end algae driven assortment of fully integrated growth systems and ingredients. We have systems ranging from 20 litres up to >1.000.000 litres. Through a high-quality, fully automated up- and downstream process we deliver a stable algae production platform base. With our process technology engineers and team of scientists we guarantee high performing algae growth systems and ingredients … | 3 | 0 | 3 | 14 |
 | Cellbox Solutions LIVE CELL SHIPMENT Cellbox Solutions is a young technology company focusing on delivering innovative and new solutions for the correct handling of living cells and biologic structures. Our product Cellbox is a self-sustaining carbon dioxide incubator supporting the appropriate storage, reproduction, transportation and analysis of biologic materials. The incubator’s temperature and gas environment can be adjusted based on the biosphere necessary for the cultivating cells stored. Biotechnology, Cell Transportation, Temperature Regulation, BioTech, Logistics, CO2 Solutions, Cell Cultures, Biological Structures, Preclinical Services, Live cell transport, portable CO2 incubator, and portable incubator Type: | 3 | 0 | 3 | 24 |
 | SolasCure Transforming chronic wound care with breakthrough enzymatic technology SolasCure is developing Aurase Wound Gel, its first investigational product, which is a single, effective and easy-to-use solution with strong IP, for all elements of chronic wound care in hospitals, clinics and homes. With over 100 million patients globally suffering from chronic wounds, debridement & wound bed preparation remain a huge unmet need in the face of rising prevalence and pressured health systems. Our mission is to overcome these challenges to transform chronic wound care. Aurase Wound Gel consists of tarumase, a highly-specific fibrinolytic enzyme isolated & cloned from maggot saliva in … Type: | 2 | 1 | 1 | 19 |
 | GenomeUp Digital biotech startup offers an ecosystem of AI-powered solutions for genetic analysis and clinical decision support for rare diseases Type: | 0 | 0 | 0 | N/A |
 | QuantrolOx Machine Learning for Quantum Control QuantrolOx is the developer of Quantum EDGE software for qubit, and quantum processor tune up automation. We envision a world where the bring-up, characterisation and testing of every qubit will be fully automated enabling quantum scientists to spend less time tuning qubits and more time advancing quantum computing, thereby accelerating the path to practical quantum computers. Quantum EDGE integrates with major quantum hardware providers by building on open-architecture principles enabling organisations to select the best components for their quantum systems. Find out more at www.quantrolox.com Quantum computing, automated qubit control, software, qubits, qubit control, and … Type: | 6 | 0 | 5 | 26 |
 | PhiTech Bioinformatics More Omics into Clinics PhiTech Bioinformatics translates genome-wide molecular data (Genomics, Transcriptomics, Epigenomics, Microbiomics, etc.) into biotechnology solutions primarily for use in precision medicine. We are moving beyond genomics by applying cutting-edge algorithms to extract information critical for diagnostic decision making. We are currently focusing on development of RNA-based diagnostics. Follow us on Twitter @PhiTech_Bioinfo Bioinformatics, Genomics, Transcriptomics, Epigenomics, and Microbiomics Type: | 0 | 0 | 0 | 24 |
 | Virax Biolabs Innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Virax Biolabs is an innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. medical device development, medical device distribution, Logistics, Procurement, Distribution, IOTH, Innovation, T-Cells, and immunology Type: | 0 | 0 | 0 | 18 |
 | Orchard Therapeutics - U.S. Dedicated to transforming the lives of patients with severe and other genetic diseases through innovative gene therapy. Orchard Therapeutics, a Kyowa Kirin company, is a global gene therapy leader focused on ending the devastation caused by genetic and other severe diseases by discovering, developing, and commercializing new treatments that tap into the curative potential of hematopoietic stem cell (HSC) gene therapy. In this approach, a patient’s own blood stem cells are genetically modified outside of the body and then reinserted, with the goal of correcting the underlying cause of disease with a single treatment. Founded in 2015, Orchard’s roots go … Type: | 2 | 2 | 0 | 208 |
 | Nuage Therapeutics We develop new selective and potent drugs for intrinsically disordered targets. Nuage Therapeutics is a spin-off from the Institute for Research in Biomedicine (IRB Barcelona) and ICREA. Nuage Therapeutics mission is to leverage biomolecular condensation and chemical biology to develop selective inhibitors of intrinsically disordered proteins involved in challenging indications representing unmet medical needs. Type: | 4 | 1 | 2 | 20 |
 | EFFECT Photonics EFFECT Photonics is a highly vertically integrated, independent leader in integrated photonics. Where Light Meets Digital - EFFECT Photonics is a highly vertically integrated, independent photonic optical systems company addressing the need for high-performance, affordable optic solutions driven by the ever-increasing demand for bandwidth and faster data transfer capabilities. Using our proprietary Digital Signal Processing and Forward Error Correction technology and Ultra-pure Light Sources, we offer compact form factors with seamless integration, cost efficiency, low power, and security of supply. By leveraging established microelectronics ecosystems, we aim to make our products affordable and available in high volumes to address the … Type: | 6 | 1 | 2 | 115 |
 | Cocoon Bioscience Proteins For Sustainability Cocoon Bioscience specializes in the manufacturing of high performance growth factors and enzymes using an automated platform leveraging cocooned insects as natural, low cost bioreactors. Type: | 1 | 1 | 0 | 26 |
 | Vivasure Medical Ltd. PerQseal® - Minimal Vascular Complications – Simply Delivered Vivasure Medical Ltd. is an ISO 13485 registered medical device company based at Europe’s leading MedTech cluster in Galway, Ireland. Founded in 2009, the company is led by an experienced management team and backed by a syndicate of international venture capital investors and state agencies. The company has developed and patented the world’s first fully absorbable, patch-based closure device specifically designed to seal large-bore arteriotomies in endovascular procedures. Please, refer to our website for further information. Medical Device, Vascular Closure, Design & Development, ISO 13485, and CE Mark Type: | 0 | 0 | 0 | 40 |
 | EV Biotech Accelerating Strain Development EV Biotech is a microbial cell factory (MCF) strain development company. EV Biotech distinguishes itself by the use of state-of-the-art computational modelling. Using cutting-edge scientific developments in systems biology we create computational models of bacterial strains to predict most optimal strain modifications, growth media supplementation and scale up optimization in line with the rational design strategy. Fast-feedback loop between strain modellers and engineers increases development speed and efficiency of the MCF strain development pipeline. Preliminary models can be updated and enhanced quickly if needed, due to a close collaboration between a theoretical and experimental departments. EV Biotech … Type: | 4 | 0 | 4 | 20 |
 | Teitur Trophics Teitur Trophics is a biotech company developing novel treatments for neurodegenerative diseases. | 0 | 0 | 0 | 16 |
 | mbiomics GmbH Casting light on the microbiome We founded mbiomics to improve peoples lives by providing a novel approach to fully understand the secrets of the microbiome with the goal to better inform targeted therapies and how to lead a healthy life. microbiome, precision medicine, biotechnology, diagnostics, immuno-oncology, and companion diagnostics | 2 | 1 | 1 | 22 |
 | Eventum Orthopaedics Ltd Accessible innovation designed to improve patient outcomes Yorkshire based Med Tech company specialising in Orthopaedics. A small company planning on making a big impact ! Orthopaedics, Medical Devices, and Innovation Type: | 0 | 0 | 0 | 9 |
 | Lunaphore Accelerating Spatial Biology. A Bio-Techne brand. Lunaphore Technologies S.A., a Bio-Techne brand, is a Swiss-based life sciences company founded in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore has developed a game-changing chip technology which can extract spatial proteomic and genomic data from tumors and transform any simple assay into multiplex spatial biology without complexity. Lunaphore empowers researchers to push the boundaries of research to ultimately develop the next generation personalized therapies. Microfluidic technology, Immunohistochemistry, Cancer Research, Immuno-oncology research, Immunofluorescence, and Multiplex Type: | 2 | 2 | 0 | 158 |
 | QuantWare Accelerating the advent of the Quantum Computer. QuantWare develops, designs and manufactures quantum processors. Our hardware enables customers to build scalable quantum computers that will be able to solve real-world challenges in climate, life sciences and beyond. Our mission is to accelerate the advent of the Quantum Computer. Visit QuantWare.com to learn more. Quantum, QPU, TWPA, Quantum Processors, Quantum Amplifiers, Quantum Computing, Superconducting, and qubit Type: | 5 | 1 | 4 | 49 |
 | GenoME Diagnostics Ltd Improving the ovarian cancer diagnostic pathway through earlier and more accurate diagnosis. GenoME Diagnostics is a spinout from the prestigious Patrick G Johnston Centre for Cancer Research at Queen’s University Belfast. We are developing novel blood tests for earlier and more accurate detection of ovarian and pancreatic cancers. GenoME Diagnostics aims to reduce the misdiagnosis and late detection to improve patient survival and outcome. Our pipeline could be applied to biomarker discovery and development in a wide range of diseases and applications. | 0 | 0 | 0 | 5 |
 | FIRE1 Our purpose is to help millions of people living with heart failure to get their normal back. FIRE1 aims to improve patient quality of life, and patient outcomes, while lowering overall healthcare costs. Health Tech, Research & Development, Medical Devices, Software Engineering, and Clinical Type: | 2 | 1 | 0 | 67 |
 | Noema Pharma Developing therapies to restore functioning in patients with orphan conditions of the brain and nervous system. Noema Pharma is a biotech company developing groundbreaking therapies to address the most disabling symptoms in orphan conditions of the brain and nervous system. Noema’s research and development is focused on understanding and meeting patient needs using our novel therapies. CNS | 1 | 1 | 0 | 30 |
 | Giotto Compliance Start automating and digitalizing your CER literature reviews. Giotto Compliance is an all-in-one platform to automatize, digitalize, and standardize the data collection, analysis and writing of a Clinical Evaluation Report. Our customers (MedTech companies worldwide) happily use Giotto Compliance to save an impressive amount of time and move into a digitalized and organized CER workflow with a strong automation component. OUR MISSION: Redefine how people and technology work together on the Clinical Evaluation of medical devices in the context of regulatory activities. OUR STORY: Giotto Compliance is developed and distributed by L2F SA, a Swiss technology company that was born … Type: | 1 | 0 | 1 | 33 |
 | Pludi EU #plant #biotech #verticalfarm Biotechnology research and development Type: | 0 | 0 | 0 | N/A |
 | DNTOX GmbH Safe chemicals for a healthy brain development without animal experiments We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, it is supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want … Type: | 4 | 0 | 4 | 8 |
 | Sensius Balanced Treatment Sensius is focused on establishing thermotherapy as a key treatment modality for cancer patients alongside radiotherapy, surgery, chemotherapy, and immunotherapy. Sensius mission is to deliver optimized radiotherapy treatment outcomes for patients with head and neck cancer, by balancing efficacy with quality of life. medical device, hyperthermia, oncology, head and neck cancer, and thermotherapy Type: | 0 | 0 | 0 | 11 |
 | Scatterin Scatterin is the Software that enables businesses to analyse materials using the world's most powerful microscopes. Type: | 0 | 0 | 0 | N/A |
 | ADC Therapeutics Innovating Science. Inspiring Hope. ADC Therapeutics is a commercial-stage biotechnology company improving the lives of those affected by cancer with our next-generation, targeted antibody drug conjugates (ADCs). With an ADC platform validated by the FDA approval of ZYNLONTA® and a deep understanding of the oncology treatment landscape, we are working to address significant unmet medical needs and improve outcomes for those with difficult-to-treat hematological cancers and solid tumors. Founded in 2011, ADC Therapeutics is based in Lausanne, Switzerland, with operations in London (R&D), New Jersey (Clinical and Commercial), and the San Francisco Bay Area (CMC). Our highly skilled global team … Type: | 1 | 0 | 1 | 301 |
 | Viva In Vitro Developing novel diagnostics compact devices to enable hospitals a better stratification of sepsis in patients. Viva’s drive is saving lives by reducing in-hospital mortality from sepsis, which is the leading cause of in-hospital deaths in the world. Our mission is to develop advanced and easy-to-use devices to solve the current problem of stratification of patients in sepsis, and in other inflammatory processes; as well as contributing to the development of novel therapies using cutting-edge scientific knowledge in the area of inflammasomes. sepsis , IVD, diagnostics, medical devices, biotech, prognosis, stratification, septic shock, acute inflammation, inflammatory diseases, inflammasomes, nlrp3, biomedical, and … Type: | 1 | 0 | 1 | 9 |
 | Linari Medical [Automatic translation follows] Technologies for neurovisual telerehabilitation of hemianoptic patients. Linari Medical has patented an innovative technology for remote visual rehabilitation of brain-damaged visually impaired patients called AvDesk. The system consists of a medical device that emits special audio-visual stimuli based on the patient's disease and processes the patient's feedback in the cloud to be analyzed remotely by a specialist. AvDesk is a class I medical device and can be used in doctors' surgeries or even at home. telemedicine, CVI, low vision, e-health, visual rehabilitation, low vision, hemianopia, quadrantopsia, tele rehabilitation, and healthcare Type: | 2 | 0 | 2 | 8 |
 | Gaia Turbine SA [Automatic translation follows] Innovative High-Performance Hydro Turbines Gaia Turbine has developed a plug-and-play hydroelectric microturbine with an efficiency of over 90%. The maximum application potential of this machine lies in the following types of installations: mini and micro-systems, minimum vital flows (DMV) and aqueducts. A Swiss reality that blossomed from the idea of the inventor Franco Tommasini and the commitment of a heterogeneous group of young entrepreneurs and local professionals with experience in the service and industrial sectors. Gaia Turbine SA has received several awards and taken part in Swiss and European acceleration programs. cleantech, energy, and deeptech Type: | 0 | 0 | 0 | 4 |
 | Ascend Advanced Therapies Ascend is a gene therapy development partner with a flexible platform featuring industry-leading analytics. Ascend is a development partner that supports life-science innovators in bringing gene therapy products to patients. Our team has deep expertise in gene therapy development and commercialization to offer unparalleled collaboration while working to develop your products from the bench through the clinic and beyond. Scientific innovation driven by quality and responsibility are at the core of our business. To set a new standard in the industry, we have invested in a world-class analytical toolkit within our flexible and scalable AAV platform of next-gen technologies, all … Type: | 2 | 0 | 2 | 115 |
 | Rarity Bioscience Ultra-sensitive and multiplex nucleic acid assays for fast and cost efficient mutation detection in liquid biopsy Rarity Bioscience provides ultrasensitive multiplex assays for mutation detecting in blood and other liquid biopsies for research, pharma and clinics. The sensitivity of our precision diagnostics technology enables patient stratification, treatment choice & monitoring, early MRD and relapse detection and post-transplantation follow-up for optimized cancer care. It also enables refined inclusion stratification and monitoring in clinical trials. The company was founded 2021 based on a discovery by Dr Lei Chen, PhD in molecular biology and a member of Professor Ulf Landegrens team at the … | 1 | 0 | 0 | 18 |
 | Spexis AG Life-changing therapies for rare disease and oncology patients. Merger between EnBiotix Inc. and Polyphor AG. Spexis AG (SIX:SPEX) is a publicly-listed Swiss clinical-stage biopharmaceutical company developing rare disease and oncology treatments in indications where new therapeutic options are urgently needed. Spexis AG was launched in December 2021 by the reverse merger of EnBiotix, Inc. (Boston, MA, USA) and Polyphor AG (Allschwil, Switzerland), with EnBiotix shareholders resulting in the majority. Our focus is on chronic respiratory diseases (CRD), and our lead product candidate ColiFin® is P3 ready. ColiFin® is an inhaled colistimethate sodium product in-licensed from PARI Pharma GmbH for ex-European … Type: | 0 | 0 | 0 | 27 |
 | 52North - creators of Neutrocheck® Reinventing the healthcare journey. At 52North, we are reinventing the healthcare journey. We are doing this by developing fully-integrated clinical, AI and medical-device based systems to improve healthcare delivery and quality of life. We create affordable technologies that empower people and enable decentralised clinical decision-making. We prioritise human-centred design and engage with people living with disease throughout our product life-cycle to reinvent their healthcare journeys. Type: | 4 | 2 | 4 | 14 |
 | biologit Accelerating Patient Safety: Leading with Evidence, AI and Scientific Expertise Biologit specialises in active safety surveillance solutions for the life sciences, including human and veterinary pharmacovigilance, cosmetovigilance, nutravigilance, and materiovigilance. Biologit MLM-AI is a comprehensive platform designed to monitor the scientific literature for adverse events and new risks related to products from clinical development to post-market. Built for teams of all sizes, its flexible workflow, global and local unified scientific database and unique AI enabled screening and productivity features deliver fast and fully traceable results for any safety surveillance screening requirements. Biologit offers a complete portfolio of services, including Qualified … Type: | 0 | 0 | 0 | 17 |
 | Nodus Oncology Developing next generation DDR targeting therapies Nodus oncology is developing first and best-in-class molecules inhibiting novel targets within the DNA damage response and replication stress response. Supported by most recent scientific advances, we are developing the next wave of cancer therapeutics in the DNA damage response (DDR) area. Founded by Cumulus Oncology and in partnership with the Lead discovery Center, Nodus Oncology is developing an innovative portfolio focused on synthetic lethality and collateral vulnerabilities in molecularly defined cancer patient populations Oncology Type: | 0 | 0 | 0 | 7 |
 | Ancora.ai Ancora.ai is a patient-first, digital clinical trials hub connecting cancer patients to trials. Our vision at Ancora.ai is that all cancer patients have access to clinical research as a care option. Ancora.ai's precision medicine trial matching technology enables personalized trial results for any patient, anywhere in minutes. Our digital, direct-to-patient platform effortlessly pre-screens and refers cancer patients to clinical trials for a better patient experience and faster referral. Our technology reduces the burden of clinical trial referrals across the healthcare ecosystem, democratizes access to trials, and accelerates recruitment timelines. We're looking for strong partners who share our vision to bring … Type: | 2 | 0 | 2 | 9 |
 | Valo Therapeutics Ltd Reinventing Cancer Immunotherapy Valo Therapeutics (ValoTx) is a developer of novel immunotherapies in cancer and infectious disease. Our unique approach to immunotherapy, based on oncolytic viruses and viral vectors combined with disease-specific peptides, delivers highly adaptable and immunogenic therapeutic vaccination platforms. A spin-out company from the University of Helsinki, Finland, Valo Tx has assembled a talented team of immunotherapy experts, who together with the founding scientists have the necessary expertise to take its patented technology through clinical development and make it available to patients. The management team has a proven track record of developing successful companies from a laboratory idea … Type: | 0 | 0 | 0 | 16 |
 | nuclivision A new perspective on nuclear medicine. We are on a mission to help patients by improving the quality, safety and accessibility of nuclear imaging. Our software solutions will assist the physician along the entire workflow, from image acquisition to diagnosis and follow-up. AI, Nuclear imaging, Nuclear medicine, Cloud computing, Computer Vision, Python, Machine learning, Medical imaging, and Oncology Type: | 1 | 1 | 1 | 6 |
 |  Fada Medical Improving the delivery of insulin for people with type 1 diabetes through extended wear devices Fada Medical's mission is to optimize chronic drug therapy, making life easier for the people who need it. Starting with insulin delivery for those with type 1 diabetes, Fada Medical are developing novel diffusion technologies to prevent and negate the causes of early infusion set failure and cannula occlusion that make insulin therapy more difficult. Type: | 0 | 0 | 0 | 2 |
 | Telea Telea | An award-winning software that links Speech Therapists and their clients Telea | An award-winning software that links Speech Therapists and their clients to enable therapists to provide at-home speech therapy. Type: | 1 | 0 | 1 | 5 |
 | Recolony AG Bacteria-based cancer therapy Recolony is a Swiss biotech start-up with the goal of developing a bacteria-based oral therapy to treat and prevent cancer. Type: | 1 | 0 | 0 | 8 |
 | NRG Therapeutics Mitochondrial therapeutics for the treatment of neurodegenerative diseases Type: | 5 | 0 | 5 | 11 |
 | TILT Biotherapeutics Ltd To make T-cells kill cancer, TILT is the answer TILT Biotherapeutics Ltd is a clinical stage company working in oncology towards enabling T-cell therapies and immune checkpoint inhibitors with oncolytic viruses. Embodiments of the technology will be used to enhance tumor infiltrating lymphocytes (TILs), chimeric antigen receptor T cells (CAR T) and immune checkpoint inhibiting antibody therapies. TILT was founded by Pr. Akseli Hemminki, who has published hundreds of papers in the field and treated almost 300 patients with 10 different oncolytic viruses. In 2013, Pr. Hemminki started his second company, TILT Biotherapeutics Ltd, with a technology based on his … Type: | 4 | 0 | 4 | 24 |
 | Droplet IV Medicine belongs in patients - not in the trash! 💧 Droplet IV is a need-driven MedTech start-up founded by doctors and engineers. Droplet started in the BioMedical Design Novo Nordisk Foundation Fellowship Programme and is currently in the Venture House incubator program at BioInnovation Institute. Problem: ≈20% of intravenous (IV) medicine is trapped as residual medicine in IV lines and never reaches the patient leading to significant underdosing. To mitigate this patient risk, nurses must spend an avg. of 2-3 minutes to flush each IV line manually. This is unrealistic and not scalable with the growing global nurse shortage. Solution: … Type: | 2 | 0 | 2 | 15 |
 | Sendance Sendance develops and sells electronics and sensors on permeable, stretchable, and structurally adapted substrates. | 0 | 0 | 0 | N/A |
 | Trovant Innovative technology for biogas and biomethane. Born in 2018, we specialize in the development and scale-up of environmental technology. We are now developing Nidup, a simple, cost effective biogas upgrading technology, based on biological and natural processes, and specifically designed for small scale and distributed biomethane generation. Highlights: - Winner: 2nd Prize Explorer Awards, Santander Explorer Entrepreneurship Program (2018). - First external startup joining the Enagas Emprende incubation program (2019). - Supported by the EC H2020 Research and Innovation Program, SME Instrument Phase I (2019). - Supported by the NEOTEC Program (2020), Spanish Ministry of Science and Innovation. - Startup … | 1 | 0 | 1 | 7 |
 | Terapet SA Next Generation Imaging Technology | 0 | 0 | 0 | 12 |
 | Angiodroid Automated Carbon Dioxide Angiography with Angiodroid the CO2 Injector Angiodroid SpA is an Italian innovative Company that projects and trades solutions for the medical market. Angiodroid® The CO2 Injector is our main product. It is a Carbon Dioxide (CO2) Injector for Interventional Radiology procedures and represents the perfect solution for the treatment of patients with: • Contrast Induced Nephropathy (CIN) risk • Diabetic Disease • Renal Failure • Intolerance to Iodinated contrast media The use of CO2 in Peripheral Angiography has been common practice for many decades. To date, however, it has not the proper success due to the lack … Type: | 2 | 0 | 0 | 46 |
 | Maxion Therapeutics Ion channel and GPCR drug discovery using innovative KnotBody technology Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins. Type: | 1 | 0 | 1 | 30 |
 | Vitalthings Improving people’s lives Vitalthings is developing medical technology for human vital signs detection and analysis. Somnofy cloud-based services for sleep research enable advanced analysis, historical data, triggers, and notifications. Visit somnofy.com for more information. Medical Technology, Sleep Sensor, Sleep, Health, and Elderly Care Type: | 0 | 0 | 0 | 37 |
 | NeoDynamics Introducing NeoNavia® – The next generation of tissue sampling. NeoDynamics AB (publ) is a Swedish medical technology company dedicated to improving diagnostics and care to optimize individualized treatment in breast cancer. We are proud to introduce NeoNavia® - a modern biopsy system with patented pulse technology based on research from the Karolinska Institute in Sweden. The pulse biopsy system ensures optimal needle control with maximum tissue yield for any lesion type, size or location. For a reliable diagnosis and more prompt treatment. Type: | 0 | 0 | 0 | 19 |
 | FluoSphera The only company with a suite of systemic and high-throughput in vitro drug discovery solutions FluoSphera S.A. is the only company providing a suite of high-throughput, systemic, in vitro drug discovery solutions. Its proprietary chip-free platform uses flexible 3D cell systems that mimic the complex biology of the human body to rapidly and precisely study human response to systemic drug delivery. FluoSphera offers four distinct drug discovery solutions: (1) multiplexing for target selectivity, (2) measuring systemic efficacy and toxicity, (3) systemic biomarker identification, and (4) translational species optimization. Type: | 6 | 0 | 6 | 4 |
 | Oxford Quantum Circuits (OQC) We build quantum computers and enable life-changing discoveries. Quantum computing is poised to reshape our world by addressing the complex challenges we face today. We deliver enterprise-ready quantum solutions that will empower humanity with quantum capabilities, paving the way for a brighter future. quantum, Computing, hardware, physics, electronics, cryogenics, quantum software, and quantum hardware Type: | 11 | 1 | 8 | 108 |
 | ChipTech Twente Europe's gateway for innovative Chip Design and heterogeneous systems Twente is on the national and international map as a hotspot for semicon and specifically for analogue chip design, photonics and as an important supplier to ASML. With a strong Integrated Circuit Design department at the University of Twente headed by professor Bram Nauta, the MESA+ institute and around 50 semiconductor-related SMEs, customers worldwide benefit from the unique knowledge of Twente. These companies have one thing in common: they all work closely with the University of Twente and Saxion University of Applied Sciences, which have a long and impressive history and … Type: | 9 | 0 | 9 | 1 |
 | Ocean Rainforest Ocean Rainforest offer a collection of premium fully-traceable seaweed products, mostly for food and cosmetic producers. | 0 | 0 | 0 | N/A |
 | Nanoflex Robotics Endoluminal Soft Robotics Nanoflex Robotics is a spin out from ETHZ developing endoluminal soft robotic systems that can be remotely manipulated within the body. We're focused on Interventional Neuro Radiology procedures for the access to and treatment of Ischemic and Hemorrhagic stroke. Stroke, Medical Device, Neuro Radiology, Telemedicine, and Neuro Surgery Type: | 1 | 0 | 0 | 24 |
 | planqc creating quantum computers atom by atom planqc's quantum computers store information in individual atoms – nature's best qubits. Quantum information is processed by arranging these qubits in highly scalable arrays and manipulating them with precisely controlled laser pulses. planqc’s unique combination of quantum technologies is the fastest way to scale to thousands of qubits, a prerequisite for industry-relevant quantum advantage. planqc's founding team combines decades of international research on neutral-atom quantum technologies. Our quantum computers are built on the precision of the world’s best atomic clocks, the world’s best quantum gas microscopes, and high-speed Rydberg gates. planqc is the first … | 3 | 1 | 1 | 39 |
 | Reshape Biotech Developing accessible automation solutions to allow researchers to spend their time more efficiently Reshape Biotech is building the next generation of lab automation robots. Our customers are biotech companies tackling the world’s biggest problems - be it alternative protein development or sustainable agriculture. Reshape Biotech is the scaling factor for these companies, as we let researchers collaborate globally on experiments and increase their throughput >500x. The team is highly multi-disciplinary, employing everything from PhD’s in biology to hardware and software engineers. We work closely together, and you will be exposed to a truly vertical team. We’re a fast growing startup … Type: | 2 | 2 | 0 | 38 |
 | Resalis Therapeutics Tackling metabolic disorders with non-coding RNAs Resalis Therapeutics’ transformative metabolic disease approach targets a master regulator of key pathways underlying obesity and fatty liver disease. The company is applying its unique understanding of the non-coding RNA drug modality and lipid metabolism to develop its lead program, RES-010, into a safe and convenient treatment providing disease-modifying therapeutic impact including durable weight loss and reduction of hepatic steatosis. Building on robust preclinical evidence, Resalis will rapidly bring RES-010 into clinical trials for a range of metabolic disorders. Type: | 0 | 0 | 0 | 9 |
 | Evonetix Ltd Technology to ignite the biology revolution We are a Cambridge-based company developing a radically different approach to gene synthesis. Our desktop DNA synthesis platform will provide the ability to synthesise DNA at unprecedented accuracy, scale and speed, accelerating scientists' ability to use synthetic biology on a scale not currently possible. Biotechnology, Synthetic Biology, DNA synthesis, Gene synthesis, and synbio Type: | 3 | 0 | 3 | 52 |
 | Five Alarm Bio Limited Boosting the body's ability to defend against the damage of aging Five Alarm Bio is a drug discovery company based in Cambridge, UK focusing on novel approaches to anti-aging, with broad potential therapeutic application. We are researching therapeutics that boost the body's ability to defend against the damage of aging. Type: | 0 | 0 | 0 | 4 |
 | UNISERS Universal Contamination Analyzer UNISERS builds and sells machines applying a novel technology to find and identify critical contaminations all along the semiconductor manufacturing chain. We help to reduce the enormous amount of contaminated and hence actually unusable and wasted newly produced microchips. wafer inspection, optics, nanotechnology, nanoparticles, semiconductor, surface analysis, and liquid analysis | 0 | 0 | 0 | 24 |
 | Hemab Therapeutics The next generation of therapeutics for bleeding and thrombotic disorders Hemab is a clinical-stage biotech company developing the first prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders. Based in Cambridge, Massachusetts and Copenhagen, Denmark, Hemab is progressing a pipeline of monoclonal and bispecific antibody-based therapeutics to transform the treatment paradigm for patients with high unmet need. The company’s strategic guidance, Hemab 1-2-5, targets the development of 5 clinical assets by 2025 to deliver long-awaited innovation for patients with high unmet need blood clotting disorders like Glanzmann Thrombasthenia, factor VII deficiency, Bernard Soulier Syndrome, Von Willebrand Disease and other serious … Type: | 1 | 0 | 1 | 45 |
 | TissueLabs The platform for creating organs and tissues in the lab. The platform for creating organs and tissues in the lab. Biotechnology, Biomaterials, Bioprinting, 3D Cell Culture, Tissue Engineering, Hydrogels, Regenerative Medicine, Research, and Tissue Culture Type: | 2 | 1 | 0 | 13 |
 | Santhera Pharmaceuticals We are dedicated to developing medicines to meet the needs of patients living with rare diseases. Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular diseases with high unmet medical need. The Company has an exclusive license from ReveraGen for all indications worldwide to AGAMREE® (vamorolone), a dissociative steroid with novel mode of action, which was investigated in a pivotal study in patients with Duchenne muscular dystrophy (DMD) as an alternative to standard corticosteroids. AGAMREE for the treatment of DMD is approved in the U.S. by the … Type: | 0 | 0 | 0 | 74 |
 | Alvotech Better Access. Better Lives. Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars. Biopharmaceuticals, Research and Development, Biosimilars, Biotechnology, Pharmaceutical, Biogenerics, Health, Cell Line Development, Business Development, and Regulatory Type: | 0 | 0 | 0 | 884 |
 | VenomAid Diagnostics VenomAid Diagnostics is a company that provides clinically rapid diagnostic tests for snakebite envenoming. | 0 | 0 | 0 | N/A |
 | Tetra Pharm Technologies Targeting the Endocannabinoid System (ECS) Tetra Pharm is a research focused biopharmaceutical company delivering cannabinoid based therapies. Type: | 2 | 0 | 2 | 34 |
 | GlaucoT Innovation for Sight - The World's First Neuroprotective Glaucoma Treatment Device - GlaucoT is a smart wearable device designed for gamma rhythm entrainment in order to reduce neuroinflammation. GlaucoT wearable device is smart glasses that provides gamma rhythm stimulation without requiring any medicine or any type of surgical operation. Patients will wear the smart glasses one hour per day at the home comfort. Type: | 0 | 0 | 0 | 4 |
 | Science4Tech Smarter Tech, Faster Therapies We are dedicated to advancing access to numerous technological innovations, elevating the quality, rigor, and reliability of clinical research rooted in the scientific method. Our commitment is to be instrumental in accelerating drug development, supporting pharmaceutical and biotechnology companies to bring therapies to patients swiftly and efficiently. AI, Machine Learning, Technology, Data, and Adaptive Clinical Trials Type: | 0 | 0 | 0 | 32 |
 | Incooling Next generation 2 phase cooled servers dedicated to achieving the fastest and greenest compute in the world. Incooling was founded after a joint initiative of Eindhoven Start-up Alliance with members including ASML and Philips, using CERN developed technology to create strategically important deep tech ventures. Originally designed to cool the largest scientific experiment on the planet – the Large Hadron Collider at CERN, Incooling adapted the unique properties of two phase cooling and created a next generation 2 phase cooled server dedicated to achieving the full potential of the data centre industry. Cooling Systems, Computer Performance, Computer Hardware, Supercomputing, Artificial … Type: | 7 | 0 | 7 | 10 |
 | Alithea Genomics Large scale RNA sequencing. Made easy. High throughput RNA sequencing, made easy. | 2 | 2 | 0 | 22 |
 | QNA Technology Quantum dots & quantum inks producer We are the producer of blue-light emitting, heavy metal-free quantum dots, there is a demand for them in light using, advanced technology markets. We are also a developer of quantum dot-based inks, which are desirable the most in printable optoelectronics. We are active since 2016, and one of the leaders in the development of colloidal semiconducting quantum dots technology. We specialize in the development and manufacturing of semiconducting quantum dots and modification of their surfaces. This way, we guarantee the highest quality of nanostructures that meet and exceed diverse client needs in various applications. … Type: | 1 | 0 | 1 | 25 |
 | AI Medical Technology Developing AI powered diagnostic solutions enabling healthcare providers to make faster and more reliable diagnoses. We are dedicated to developing AI powered diagnostic solutions that enable frontline healthcare practitioners to make easier, faster and more reliable diagnoses for their patients. Our first product, Dermalyser, is undergoing clinical validation as a decision support tool for the diagnosis of all skin cancers. skin cancer and AI Diagnostics Type: | 1 | 0 | 0 | 11 |
 | AQ Trials A unique cloud based platform designed to optimise trial delivery at investigator sites AQ clinical trial software has been developed by clinicians with over 20 years experience in healthcare and research. Our passion to deliver new drugs to patients led us to design and build a solution that can support sites conduct research and improve patient recruitment and retention in clinical trials. HelathTech, ClinicalTrials, SaaS Platform, Appointment & Scheduling, Research, ISF, Data & Analytics, and ctms Type: | 0 | 0 | 0 | 6 |
 | Molymem Ltd. Developing a new-class of functional and sustainable membranes Molymem Ltd is a University of Manchester spin-out commercialising technology to improve existing filtration membranes for separation applications in a wide range of markets, including desalination and removal of industrial pollutants. water filtration, membranes, desalination, separation science, MoS2, and 2D materials Type: | 1 | 0 | 1 | 10 |
 | PamGene International B.V. Offering functional Kinase activity profiling assays for signalling and biomarker research PamGene is a functional proteomics Company with a unique 3D array platform to measure the ACTIVITY of Tyrosine and Serine/Threonine kinase. We offer Products (described in our Showcase pages, PamStation-12 ®, Pamchip arrays ® and Reagent kits) and Services (lead optimization, translational/ preclinical research and biomarker discovery). We have developed powerful software tools (BioNavigator) for complex data analysis with which you can interpret results in a biological context. We support clinical trials in the oncology area. Pamgene is advancing research in Oncology as well as other areas (Neurobiology, Immunology, … Type: | 0 | 0 | 0 | 39 |
 | PROTEROS biostructures GmbH REACH RIGHT FASTER Proteros is a privately held early-stage services provider in structure-based drug discovery with a cutting-edge discovery engine tailored to unlock even the most technically challenging targets. Proteros’ work is built on scientific excellence and supports its clients to reach the right results and accelerate their overall research timelines. Proteros supports most of the world’s 20 largest pharma companies and more than 250 pharmaceutical and biotech partners in the US, Europe and Japan. For more information please visit www.proteros.com. As we continue to grow, we constantly look for committed, professional and energetic people with a high sense of … Type: | 1 | 0 | 1 | 135 |
 | Woamy The Sustainable Foam Company Woamy, an Aalto University spin-off, is bringing to the market a revolutionary plastic-free biofoam for protective packaging to replace harmful plastic foams, a solution sought after by the biggest players in the foam market and brands ranging from big electronic companies to luxury brands. Inspired by nature and backed with a decade of scientific research, our Finland-based multidisciplinary and diverse team of scientists, engineers, designers and business minds founded Woamy in 2022. Since then we have already succesfully scaled the production 10x, started pilot production, become the top 10 rising star in Finland, build an incredible … Type: | 4 | 1 | 4 | 11 |
 | Renalytix Our singular goal is to eradicate kidney disease. Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosisTM for kidney health. We’ve engineered a proprietary solution that successfully enables early-stage, progression risk assessment when it counts the most. Renalytix. Right here, until kidney disease isn’t.TM Type: | 0 | 0 | 0 | 57 |
 | Amferia Amferia kills bacteria, even resistant bacteria, without harming the body Amferia AB is a Swedish company that develops and markets new medical devices with emphasis on antibacterial products. The core focus of Amferia is to develop materials that can efficiently kill bacteria when used as medical devices, for example within wound care. Amferia is a spin-off from research performed at Chalmers University of Technology. The company was founded in 2018 and the founders of Amferia are Dr. Anand Kumar Rajasekharan, Professor Martin Andersson and Dr. Saba Atefyekta. Antibacterial materials, Antibiotic resistance, Elastomers, and Injectable Materials Type: | 0 | 0 | 0 | 9 |
 | ExeVir Rapid Viral control in a world that needs it ExeVir Bio, a spin out of VIB, is harnessing its Llama-derived antibody (VHH) technology platform to generate robust antiviral therapies providing broad protection against coronaviruses. ExeVir Bio is using a highly innovative and clinically validated VHH technology to develop treatments for viral infections that may pose a significant global threat. Our lead compound, an enhanced variant of VHH72-Fc binds to a unique epitope that is conserved in SARS-CoV-1 and SARS-CoV-2 viruses and this binding prevents these viruses from entering the cell. The importance of this approach is that it could be … Type: | 2 | 0 | 1 | 21 |
 | Autoscriber Autoscriber is unlocking the future of medical consultations through data - towards personalised, transparent and accessible healthcare Type: | 0 | 0 | 0 | N/A |
 | MIP Discovery nanoMIPs - synthetic antibodies with robust characteristics and secure supply Our proprietary technology includes a novel method to make nanoMIPs which circumvents the drawbacks of traditional MIP manufacturing methods. NanoMIPS are, as the name suggests, nanostructured polymer particles typically containing a single binding site for their target. They can also be fused to solid substrates, such as sensor surfaces, if required. The robust nature of MIPs and nanoMIPs make them ideal reagents for a wide range of applications including point-of-care diagnostics and in field based testing. As they are synthetic polymers, MIPs can withstand harsh chemical environments such as extremes … Type: | 0 | 0 | 0 | 32 |
 | OET - Organic Electronic Technologies P.C. OET (Organic Electronic Technologies P.C.) operates in the rapidly growing field of Organic and Printed Electronics (OEs). OET delivers: - Process technologies for developing OE materials & devices - Monitoring & quality control tools for the manufacturing of OEs - Integrated turn-key solutions for the manufacturing, processing and quality control of OEs OET’s expertise in OE Production Process Technology and Metrology/Quality Control Systems is further enhanced by the company’s: - Access to unique world-class OE development facilities - International network of prestigious partnerships - Participation in trail blazing research projects Type: | 1 | 0 | 1 | 15 |
 | NapiFeryn BioTech We developed and patented a #technology to obtain #food grade #proteins from #rapeseed (#canola) and other oilseeds. Beneficiary of #SMEInstrument #H2020 and the proud member of #RisingFoodStars #EITFood The NapiFeryn technology makes it possible to retrieve all protein contained in rapeseed, which makes the proposal unique worldwide. biotechnology, food industry, alternative proteins, rapeseed protein, and raptein Type: | 3 | 2 | 2 | 16 |
 | Evosep Biosystems Making clinical proteomics 100 times more robust and 10 times faster Evosep develops new solutions to make clinical proteomics 100 times more robust and 10 times faster. We are targeting the growing need for throughput with robust solutions for clinical and large-scale proteomics, and we have a very ambitious business plan to bring the community closer to the clinic. We are basing our design on years of experience with nano-UHPLC R&D and application support, critically rethinking the necessary system architectures for successful sample separation before mass spectrometric analysis. proteomics, clinicalproteomics, and LC-MS | 1 | 0 | 1 | 70 |
 | DeuterOncology NV Developing deuterated BEST in CLASS MET kinase Inhibitor DeuterOncology NV is a Liege based clinical stage biotechnology company that was founded in September 2020 by Dr Timothy Perera. The company is currently focused on the clinical development of a highly selective brain penetrant, deuterated MET kinase inhibitor DO-2. Drug Development, Deuterated small molecules, and MET kinase inhibitor Type: | 0 | 0 | 0 | 4 |
 | Vector Photonics A revolution in semiconductor lasers. Vector Photonics’ PCSELs are the first, major break-through in semiconductor laser technology for 30 years. The company is a spin-out from one of the world’s leading academic groups in Photonics at the University of Glasgow. Its proprietary technology, developed since 2012, places Vector Photonics at the heart of the rapidly growing datacenter industry. PCSELs (Photonic Crystal Surface Emitting Lasers) are low cost, robust with high speed and power. This combination of key characteristics gives them a huge advantage over present-day, commonly used VCSELs (Vertical Cavity Surface Emitting Lasers), which compromise wavelength range and power, and … Type: | 2 | 1 | 2 | 16 |
Startup